Philip Mazzara sold $5.1M of ALAB
General Counsel and Secretary at Astera Labs, Inc.. 57,536 shares at an average of $88.06, traded Feb 18, 2025, filed Feb 20, 2025.
Score components
- +15RoleOfficer
- +25Trade size$5.1M at market
- +5Share of holdings soldSold 23% of holdings
- +15Cluster6 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001736297-25-000011, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 18, 2025 | SOpen-market sale Common Stock10b5-1 | -7,536 | $92.07 | $694k | 241,209 | Feb 20, 2025 |
| Feb 20, 2025 | SOpen-market sale Common Stock10b5-1 | -6,928 | $85.80 | $594k | 234,281 | Feb 20, 2025 |
| Feb 20, 2025 | SOpen-market sale Common Stock10b5-1 | -14,170 | $86.73 | $1.2M | 220,111 | Feb 20, 2025 |
| Feb 20, 2025 | SOpen-market sale Common Stock10b5-1 | -12,949 | $87.54 | $1.1M | 207,162 | Feb 20, 2025 |
| Feb 20, 2025 | SOpen-market sale Common Stock10b5-1 | -14,760 | $88.73 | $1.3M | 192,402 | Feb 20, 2025 |
| Feb 20, 2025 | SOpen-market sale Common Stock10b5-1 | -1,193 | $89.24 | $106k | 191,209 | Feb 20, 2025 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $4.7M 12,499 shares | -25% | |
| 33Weak | Astera Labs, Inc. | Manuel Alba director | $51M 183,000 shares | -14% | |
| 33Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.4M 12,499 shares | -23% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $32M 183,000 shares | -10% | |
| 35Weak | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $1.9M 10,000 shares | -6% | |
| 40Moderate | Astera Labs, Inc. | Jack R Lazar director | $4.0M 22,500 shares | -19% | |
| 62Notable | Astera Labs, Inc. | Michael Truett Tate Chief Financial Officer | $3.5M 18,861 shares | -7% | |
| 65Notable | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $17M 91,441 shares | -4% | |
| 55Moderate | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $1.3M 7,237 shares | -4% | |
| 60Notable | Astera Labs, Inc. | Sanjay Gajendra President and COO | $17M 91,441 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.